Who is sponsoring NCT03256097?

NCT03256097 is sponsored by Oticon Medical.

What drugs are being tested in NCT03256097?

Interventions in NCT03256097: XDP sound processing strategy - Period 0, XDP sound processing strategy - Period 1, VG sound processing strategy - Period 1, XDP sound processing strategy - Period 2, VG sound processing strategy - Period 2, XDP sound processing strategy - Period 3, VG sound processing strategy - Period 3, Voice Track.

What condition does NCT03256097 study?

NCT03256097 studies Cochlear Implantation.

Is NCT03256097 still recruiting?

NCT03256097 is currently completed. Last updated 12 January 2023.

Last reviewed 2023-01-12 · How we verify

NCT03256097

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Voice Guard Processing Evaluation in a Cohort of Subjects Implanted With the Neuro Cochlear Implant System

Completed NA Last updated 12 January 2023

What this trial tests

NA trial testing XDP sound processing strategy - Period 0 in Cochlear Implantation in 21 participants. Completed in 31 May 2022.

Timeline

25 July 2018

Primary endpoint
31 May 2022

31 May 2022

Quick facts

Lead sponsor	Oticon Medical
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	21
Start date	25 July 2018
Primary completion	31 May 2022
Estimated completion	31 May 2022
Sites	2 locations across United Kingdom

Drugs / interventions tested

XDP sound processing strategy - Period 0
XDP sound processing strategy - Period 1
VG sound processing strategy - Period 1
XDP sound processing strategy - Period 2
VG sound processing strategy - Period 2
XDP sound processing strategy - Period 3
VG sound processing strategy - Period 3
Voice Track

Conditions studied

Cochlear Implantation — all drugs for Cochlear Implantation →

Sponsor

Oticon Medical

Who can join

Adults 18 to 70, any sex, with Cochlear Implantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to compare two different cochlear implant sound processing strategies. All the participants will start off with a sound processing strategy called the XDP (extended performance). At the 3 month stage, half of the participants would randomly be selected and offered a sound processing strategy called the Voice Guard. Following that, the sound processing strategies will be altered and evaluated every 3 months at the 6th, 9th and 12th month of cochlear implant use.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cochlear Implantation

Currently open trials in the same condition.

NCT06951594 — Robotic-Assisted Versus Manual Electrode Array Insertion · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
NCT06375278 — Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implan · NA · recruiting
NCT06664710 — Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery · NA · recruiting
NCT07039435 — Perceptual Adaptation Following Cochlear Implantation (Aim 3a) · NA · recruiting

Other Oticon Medical trials

Trials by the same sponsor.

NCT07294976 — Evaluation of Actual Maximum Gain in Bone Anchored Devices · NA · recruiting
NCT06930781 — Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-O · recruiting
NCT06976086 — Pediatric Expansion Study of the Sentio System · NA · recruiting
NCT06421766 — Retrospective Study of Outcomes With 3 mm Implant for Percutaneous BAHS Procedures · completed
NCT06638840 — Pediatric Performance and Satisfaction of Oticon Medical Ponto on Softband. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03256097 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oticon Medical
Last refreshed: 12 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03256097.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing